Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

FDA Panel: Keep Avandia on Market

But it may get warning label on heart risks

By the Associated Press

Posted Jul 14, 2010 3:22 PM CDT

(AP) – A majority of federal health experts has voted to keep the controversial diabetes pill Avandia on the market despite evidence that it increases the risk of heart attack. A panel of Food and Drug Administration advisers voted 20-12 against withdrawing GlaxoSmithKline's once-blockbuster drug. The agency is not required to follow the group's advice, but it usually follows the advice of its advisory committees.

Panelists who voted to keep the drug on the market were split between several options, including adding new warning labels and restricting use of the drug. Avandia has been under federal scrutiny since 2007, when an analysis first suggested it might cause heart attack.

A file photo of a bottle of Avandia. (Paul Sakuma)

A pharmacist displays three Avandia pills. (AP Photo/Paul Sakuma)

« Prev« Prev | Next »Next » Slideshow

CLICK BELOW TO VOTE

14%

52%

29%

To report an error on this story, notify our editors.

OTHER STORIES ON OUR RADAR

Getty Images

Man Goes to Hospital For Kidney Stone...Leaves a Woman (Huff Post)

Is Chase Crawford Dating a Cougar? (Bleacher Report)

My Boss Walked in on Me Touching Myself, Now He Won't Stop Flirting (Slate)

7 Gross Celebrity Items Sold at Auction (The Week)

The Lowest-Rated Show on TV Is Actually Awesome (Slate)

Partner Links

Sponsor Links

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

COMMENTS

Read the comment policy

Showing 3 of 4 comments

HMunster

Jul 15, 2010 6:09 AM CDT

Jesus! Who's finger did they use in that extreme close up photo? The Crypt Keeper's or Nancy Pelosi's? (I know, I know: They're one in the same...)

finkster

Jul 14, 2010 4:24 PM CDT

FDA: Do you have our money? GlaxoSmithKline: Yes sir here it is....sorry about missing last month's payment. FDA: Don't let it happen again and next year there will be a 15% increase...understood? GlaxoSmithKline: We understand sir. FDA: Good In other news today the FDA has decided to keep Avandia on the Market.

AustinFound

Jul 14, 2010 3:51 PM CDT

"Just keep selling it until we figure out what it does."

What's Popular Now on Facebook

Cops Shoot Naked Guy Eating Man's Face on Highway

Japanese Artist Serves Up Own Cooked Genitals

Associated Press (Source Grid »)

Money • Health

FDA • diabetes • GlaxoSmithKline • Avandia

More Newser Stories

Avandia Woes Mount Ahead of FDA Hearing

Agency flags flawed study, may ban diabetes drug

(NEWSER) - As the FDA prepares to consider whether to ban Avandia, agency scientists have discovered another problem with the diabetes drug: flaws that disqualify a clinical study sponsored by its maker. The trial, organized by GlaxoSmithKline, sought to evaluate the relative heart risks of Avandia and two other diabetes drugs, but was an "open label" trial, meaning the researchers and patients knew which drugs they were getting, USA Today reports. More»

Diabetes Drug Linked to Heart Woes Again; FDA Weighs Ban

Avandia less safe than alternatives; FDA weighs action

(NEWSER) - The mountain of evidence against diabetes drug Avandia grew a bit bigger today, with two major studies linking the medication to heart disease and stroke, the LA Times reports. An FDA panel will meet next month to discuss recalling the drug, which has been on the agency's radar at least since 2007, when a large analysis determined that Avandia raises users' risk of suffering a heart attack. More»

Feds Further Link Avandia to Heart Risk

FDA, Senate reports lambaste GlaxoSmithKline, want to yank drug

(NEWSER) - Some 800 people every month suffer heart attacks or heart failure because of the diabetes medication Avandia, according to government reports obtained by the New York Times . Under fire since 2007, the GlaxoSmithKline drug was linked to 304 deaths in the final quarter of last year and hundreds of thousands still take it. Avandia “should be removed from the market," concludes one FDA study unequivocally. More»

Diabetes Drug Given Strictest Warning Label

FDA's 'black box' adds risk of heart attack to concerns on Avandia

(NEWSER) - The FDA has applied its harshest warning to the diabetes drug Avandia, declaring the product potentially increases risk of heart attacks. Now marked with a “black box” warning, GlaxoSmithKline’s drug will stay on the market pending a continuing “safety assessment,” the Wall Street Journal reports; FDA officials say the agency remains split on the wisdom of pulling the drug immediately. More»

FDA Panel Votes to Keep Avandia on Shelves

Controversial diabetes drug still faces heart-attack link

(NEWSER) - An FDA panel said today that GlaxoSmithKline's diabetes drug Avandia should remain in drugstores, despite earlier evidence the pill ups heart failure risks. Glaxo has defended its drug, countering that the risks associated with the popular Avandia are the same as those of other diabetes drugs. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

FDA Panel: Keep Avandia on Market

But it may get warning label on heart risks

OTHER STORIES ON OUR RADAR

FDA • diabetes • GlaxoSmithKline • Avandia

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

Avandia Woes Mount Ahead of FDA Hearing

Agency flags flawed study, may ban diabetes drug

Diabetes Drug Linked to Heart Woes Again; FDA Weighs Ban

Avandia less safe than alternatives; FDA weighs action

Feds Further Link Avandia to Heart Risk

FDA, Senate reports lambaste GlaxoSmithKline, want to yank drug

Diabetes Drug Given Strictest Warning Label

FDA's 'black box' adds risk of heart attack to concerns on Avandia

FDA Panel Votes to Keep Avandia on Shelves

Controversial diabetes drug still faces heart-attack link

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?